copper tripeptide-1 vs ghk-cu Peptide Serum with 1% peptide, Argireline and Matrixyl 3 – Dr. Brenner Labs Reduce Appearance of Fine Lines Meet the ingredient your skin

Comparison of Doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

Researchers often compare DSIP with related compounds in the sleep and neuroendocrine research compound category to evaluate similarities in pathway activity, structure, and experimental response

E., La, K., Erlandson, K

A method of preventing gait abnormalities in a patient with Parkinson's disease or of improving or restoring to normal the gait of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine